Jamson Pharmaceutical Private Limited

Jamson Pharmaceutical Private Limited - pharma in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24230MP2011PTC026653 Incorporated 30 August 2011 ROC Gwalior HQ Indore, Madhya Pradesh, India
Struck Off Private Limited Company pharma
Revenue · FY 2018
₹3.8 Cr
▲ 66% YoY
Net profit · FY 2018
₹5.98 Lakh
Net margin 1.6%
EBITDA · FY 2018
₹6 Lakh
EBITDA margin 1.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Jamson Pharmaceutical Private Limited

Data last updated:

Jamson Pharmaceutical Private Limited was a private limited company based in Indore, Madhya Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 August 2011.

The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2011PTC026653. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It was led by directors Ashish Shrivastava and Sunil Kumar Joshi.

Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 9 Third Floor Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001.

As per the financials filed for FY 2018, the company reported a revenue of ₹3.8 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹5.98 Lakh (net margin 1.6%) and EBITDA of ₹6 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.

Court records list 5 cases involving the company, including 5 filed against it.

The last known website on record is jamsonpharma.com.

Company details

CIN U24230MP2011PTC026653
Registration Number 026653
Incorporation Date 30 August 2011
ROC Gwalior
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Compliant

Contact details

Jamson Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its website is jamsonpharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    9 Third Floor Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Jamson Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Jamson Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Jamson Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Jamson Pharmaceutical Private Limited, buy the company report.

Financials of Jamson Pharmaceutical Private Limited

FY 2018 filings available

Jamson Pharmaceutical Private Limited reported revenue of ₹3.8 Cr (up 66% YoY) for FY 2018.

Revenue · FY 2018
₹3.8 Cr ▲ 66%
Net profit · FY 2018
₹5.98 Lakh margin 1.6%
EBITDA · FY 2018
₹6 Lakh margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 99%
3 years · compounded
▲ 80%

Revenue has grown at a compounded annual rate (CAGR) of 52% over three years, including 66% growth in the latest year. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹3.8 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.98 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin1.6%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jamson Pharmaceutical Private Limited, buy the company report.

Board of directors of Jamson Pharmaceutical Private Limited

Jamson Pharmaceutical has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Ashish ShrivastavaDirector16 Sep 201313 Years 2 MonthsAs last reported
Sunil Kumar JoshiDirector16 Sep 201313 Years 2 MonthsAs last reported

Auditor

Jamson Pharmaceutical Private Limited is audited by Aditya Bartaria And Company. for the financial year 2018.

Auditor firmFinancial yearFirm registration number
Aditya Bartaria And Company.FY 2018022998C

Shareholding

The shareholding of Jamson Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jamson Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Jamson Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Jamson Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Jamson Pharmaceutical Private Limited, buy the company report.

Recent activity

Jamson Pharmaceutical Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Rekha Shrivastava ceased to be Additional Director on 26 Mar 2018.

AGM
Jamson Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
Filing
Jamson Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Gwalior.
Ceased
Rekha Shrivastava ceased to be Additional Director.
Ceased
Subhash Manocha ceased to be Director.
Ceased
Amit Manocha ceased to be Director.
Appointed
Ashish Shrivastava was appointed as Director.
Appointed
Sunil Kumar Joshi was appointed as Director.
Ceased
Dipali Mahajan ceased to be Director.
Ceased
Rashmi Shrivastava ceased to be Director.
Ceased
Megha Shaligram ceased to be Director.
Incorporation
30 Aug 2011
Jamson Pharmaceutical Private Limited was registered on 30 Aug 2011 with Roc Gwalior & aged 15 years 2 months as per MCA records.

Frequently asked questions

Jamson Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Jamson Pharmaceutical was a private limited company based in Indore, Madhya Pradesh, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 August 2011 and is registered under CIN U24230MP2011PTC026653. The company has been struck off by the Registrar of Companies and is no longer operational.

Jamson Pharmaceutical had 2 directors:

The CIN (Corporate Identification Number) of Jamson Pharmaceutical is U24230MP2011PTC026653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Jamson Pharmaceutical is at 9 Third Floor Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001.

Jamson Pharmaceutical was incorporated on 30 August 2011. It is registered with the Registrar of Companies, Gwalior.

Jamson Pharmaceutical can be reached through the website jamsonpharma.com. Its registered office is in Indore, Madhya Pradesh, India.

The latest financial statements of Jamson Pharmaceutical on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.

No. Jamson Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.

Jamson Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.